씨어스

458870KOSDAQ

58.8 / 100

Reference Date: 2026-09-08

Financial Score24.5 / 40

News Sentiment20.3 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 2.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Seers Technology provides IoMT platform services using AI algorithms and wearable medical devices, including mobiCARE™ for ECG analysis and thynC™ for inpatient monitoring. mobiCARE™, launched in 2020, is used by over 1,000 medical institutions with 620,000 test cases, while thynC™, launched in 2024, has achieved 12,000 installed beds. Key products include certified wearable medical devices such as ECG monitors and thermometers.

Number of Employees

130people

Average Salary

74.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

52.58Industry Average 15.000.0Point

3.5x industry avg (risky)

PBR

—Industry Average 1.203.5Point

ROE

52.59Industry Average 8.007.0Point

6.6x industry avg (excellent)

Debt Ratio

9.54Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲494.7% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲288.1% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.8% (improving, 2yr)

Detailed News Sentiment

8 totalPositive 7Neutral 0Negative 1Average Sentiment Score 81.2

Positive
씨어스, '모비케어' 미국 이어 캐나다 품목허가…북미 진출 본격화
씨어스의 AI 기반 심전도 분석 솔루션 '모비케어'가 캐나다에서 품목허가를 획득하며 북미 시장 진출이 본격화되어 긍정적인 영향을 미칠 것으로 예상됩니다.
Positive
씨어스 ‘모비케어’, 캐나다 의료기기 허가…북미 상용화 추진
씨어스의 캐나다 의료기기 허가 획득으로 북미 시장 진출이 가속화되어 긍정적인 시장 반응을 기대할 수 있다.
Positive
부산백병원, 대웅제약 '씽크' 스마트병동 확대
대웅제약과 부산백병원의 협력으로 AI 기반 스마트병동 확대 계획 발표, 씨어스 관련 직접적인 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 22,450Won52-week high 189,00052-week low 20,700

1-month return2.0Point

1m -2.39% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-08-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-14
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-14